The abrogation of the G1/S checkpoint or upregulation of the D1-type cyclins (Cyclin D1, Ccnd1)/cyclin-dependent kinases (Cdk4) pathway provides an obvious advantage to cancer cells in terms of proliferation and survival. This evidence concerns the gene CCND1 and cancer.